REGN
42
-4
CAT
61
8
MUR
39
-4
NSC
60
-4
PNW
57
-2
NWS
56
-2
IP
50
2
TRIP
50
-2
HBAN
42
-2
EIX
61
5
PRGO
14
-2
CA
15
3
OI
33
-4
FITB
58
8
ORLY
62
-11
DNB
40
-4
WM
62
2
TAP
54
-2
PSA
35
-2
CSX
48
9
REGN
42
-4
CAT
61
8
MUR
39
-4
NSC
60
-4
PNW
57
-2
NWS
56
-2
IP
50
2
TRIP
50
-2
HBAN
42
-2
EIX
61
5
PRGO
14
-2
CA
15
3
OI
33
-4
FITB
58
8
ORLY
62
-11
DNB
40
-4
WM
62
2
TAP
54
-2
PSA
35
-2
CSX
48
9
Financhill
Back

KraneShares Emerging Markets Consumer Tech Idx ETF Vs. Cidara Therapeutics Industry Stock Comparison

Buy
65

KEMQ
KraneShares Emerging Markets Consumer Tech Idx ETF

Last Price:
$22.81
Seasonality Move:
-5.31%
Buy
77

CDTX
Cidara Therapeutics

Last Price:
$62.00
Seasonality Move:
2.01%
Buy
65
KraneShares Emerging Markets Consumer Tech Idx ETF (KEMQ) is a Buy

Is KraneShares Emerging Markets Consumer Tech Idx ETF a Buy, Sell or Hold?

  • The current KraneShares Emerging Markets Consumer Tech Idx ETF [KEMQ] share price is $22.53. The Score for KEMQ is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • KEMQ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
Cidara Therapeutics (CDTX) is a Buy

Is Cidara Therapeutics a Buy, Sell or Hold?

  • The current Cidara Therapeutics [CDTX] share price is $62.00. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

KEMQ Stock Price Chart

What is KraneShares Emerging Markets Consumer Tech Idx ETF's stock price today?

  • The KraneShares Emerging Markets Consumer Tech Idx ETF share price today is $22.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KEMQ is experiencing selling pressure, which indicates risk of future bearish movement.

CDTX Stock Price Chart

What is Cidara Therapeutics's stock price today?

  • The Cidara Therapeutics share price today is $62.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight selling pressure.

KEMQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.21 Buy
Relative Strength Index (14 RSI): 51.91 Buy
Chaikin Money Flow: -1219 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.27 - 22.91) Sell
Bollinger Bands (100): (18.68 - 22.34) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 17.06 Buy
Relative Strength Index (14 RSI): 66.1 Buy
Chaikin Money Flow: -5264 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54 - 63.66) Buy
Bollinger Bands (100): (16.68 - 50.42) Buy

KEMQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.51 Buy
20-day SMA: 22.69 Sell
50-day SMA: 22.07 Buy
200-day SMA: 19.25 Buy
8-day EMA: 20.74 Buy
20-day EMA: 14.25 Buy
50-day EMA: 7.42 Buy
200-day EMA: 2.14 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 62.27 Sell
20-day SMA: 60.63 Buy
50-day SMA: 46.09 Buy
200-day SMA: 26.83 Buy
8-day EMA: 57.04 Buy
20-day EMA: 39.3 Buy
50-day EMA: 20.5 Buy
200-day EMA: 5.92 Buy

KraneShares Emerging Markets Consumer Tech Idx ETF Earnings Growth & KEMQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $4.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.92 per share, and a decrease next year of $1.83 per share.

KraneShares Emerging Markets Consumer Tech Idx ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):